About: Image Guided Hypofractionated Radiation Therapy, Nelfinavir Mesylate, Pembrolizumab, Nivolumab and Atezolizumab in Treating Patients With Advanced Melanoma, Lung, or Kidney Cancer

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Image Guided Hypofractionated Radiation Therapy, Nelfinavir Mesylate, Pembrolizumab, Nivolumab and Atezolizumab in Treating Patients With Advanced Melanoma, Lung, or Kidney Cancer Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

A clinical trial related to cancer immunotherapy, retrieved from clinicaltrials.gov

Attributes	Values
rdf:type	Item
description	klinisch onderzoek (nl) A clinical trial related to cancer immunotherapy, retrieved from clinicaltrials.gov (en)
rdfs:label	Image Guided Hypofractionated Radiation Therapy, Nelfinavir Mesylate, Pembrolizumab, Nivolumab and Atezolizumab in Treating Patients With Advanced Melanoma, Lung, or Kidney Cancer (en) Image Guided Hypofractionated Radiation Therapy, Nelfinavir Mesylate, Pembrolizumab, Nivolumab and Atezolizumab in Treating Patients With Advanced Melanoma, Lung, or Kidney Cancer (nl) Image Guided Hypofractionated Radiation Therapy, Nelfinavir Mesylate, Pembrolizumab, Nivolumab and Atezolizumab in Treating Patients With Advanced Melanoma, Lung, or Kidney Cancer (ast)
skos:prefLabel	Image Guided Hypofractionated Radiation Therapy, Nelfinavir Mesylate, Pembrolizumab, Nivolumab and Atezolizumab in Treating Patients With Advanced Melanoma, Lung, or Kidney Cancer (en) Image Guided Hypofractionated Radiation Therapy, Nelfinavir Mesylate, Pembrolizumab, Nivolumab and Atezolizumab in Treating Patients With Advanced Melanoma, Lung, or Kidney Cancer (nl) Image Guided Hypofractionated Radiation Therapy, Nelfinavir Mesylate, Pembrolizumab, Nivolumab and Atezolizumab in Treating Patients With Advanced Melanoma, Lung, or Kidney Cancer (ast)
name	Image Guided Hypofractionated Radiation Therapy, Nelfinavir Mesylate, Pembrolizumab, Nivolumab and Atezolizumab in Treating Patients With Advanced Melanoma, Lung, or Kidney Cancer (en) Image Guided Hypofractionated Radiation Therapy, Nelfinavir Mesylate, Pembrolizumab, Nivolumab and Atezolizumab in Treating Patients With Advanced Melanoma, Lung, or Kidney Cancer (nl) Image Guided Hypofractionated Radiation Therapy, Nelfinavir Mesylate, Pembrolizumab, Nivolumab and Atezolizumab in Treating Patients With Advanced Melanoma, Lung, or Kidney Cancer (ast)
instance of	wds:Q58849945-E0C84EDF-CC63-44F4-9DEB-B5CB2985538D
instance of	clinical trial
main subject	wds:Q58849945-8F5DFDAB-4FCB-4FB5-B4A6-40989A987BA4
main subject	cancer immunotherapy
research site	wds:Q58849945-A3F1D030-0FD6-4F45-9602-5986E7975EDC
research site	University of Washington
minimum age	wds:Q58849945-C7A55F49-71F5-4D2A-B641-A7DD815B7473
minimum age	18 (xsd:decimal)
medical condition	wds:Q58849945-DD636C3C-1000-46CA-8A66-7CB1B5A29D20
medical condition	lung neoplasm
study type	wds:Q58849945-5116DAC7-B1CB-43B5-9089-BE0850688BEC
study type	interventional study
ClinicalTrials.gov ID	wds:Q58849945-EC8030BB-C215-42B1-8B30-BD3B75CFAA2A
ClinicalTrials.gov ID	NCT03050060
research subject recruitment status	wds:Q58849945-C8DA573F-D8AD-47C4-840F-602093692568
research subject recruitment status	suspended
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q58849945

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 190 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software